Monitoring devices for preterm infants haven’t changed much since the ’60s. But they’re about to—and should, asserts one healthcare company executive. Here’s what you need to know about monitoring devices in the NICU—and how they are advancing.
As a biomed, bringing your talent to a developing world hospital that is struggling for sound medical equipment can be an intensely satisfying experience. For those who are thinking about making a medical mission trip to the developing world for the first time, partnering with an organization that can help prepare supplies and contacts is key to a successful experience.
According to a new study by ReportBuyer, the global infusion pump market was estimated to be worth $8.1 billion in 2016 and is expected to surge to more than $14.7 billion by 2025. The rise in the geriatric population, along with the increased prevalence of chronic diseases, is expected to boost demand for infusion pumps and drive the global market toward rapid growth.
Medtronic has announced U.S. FDA approval of its CareLink SmartSync device manager. With the introduction of SmartSync, physicians are now be able to use an Apple iPad to program and manage data from Medtronic's BlueSync-enabled implanted cardiac devices.
The global market for anesthesia and respiratory devices is slated to grow from $25.21 billion to $38.29 billion by 2023, surging at a compound annual growth rate of 7.2%. Driving market growth are the rise in respiratory diseases, an increase in surgical procedures, and high rates of tobacco consumption.
Mettawa, Ill.-based Vyaire Medical Inc., a global player in the ventilation technologies market, has signed an agreement to acquire the ventilator business and the imtmedical brand name. The traditional business unit testing devices, including test lungs, will be continued under the brand IMT Analytics and will remain in the possession of the previous ownership.